INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

67,560 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Derivative conversion · 10b5-1 plan
C—
12.8K sh
Sep 10, 2026
Page 377 of 1689
← PrevNext →
Sep 10, 2026
traded Sep 10, 2026
+0d
SEC Form 4

Evidence

0
BE
Benevich EricChief Commercial Officer
NBIXNEUROCRINE BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
3,194 sh
Sep 9, 2026Sep 10, 2026
traded Sep 9, 2026
+1dSEC Form 4

Evidence

0
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Derivative conversion · 10b5-1 plan
C—
12.8K sh
Sep 10, 2026Sep 10, 2026
traded Sep 10, 2026
+0dSEC Form 4

Evidence

0
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Derivative conversion · 10b5-1 plan
C—
12.8K sh
Sep 9, 2026Sep 10, 2026
traded Sep 9, 2026
+1dSEC Form 4

Evidence

0
KC
Kleinerman ChristianEVP, Product Management
SNOWSnowflake Inc.
Tax withholding · 10b5-1 plan
F$305K
904 sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

0
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Derivative conversion · 10b5-1 plan
C—
12.8K sh
Sep 9, 2026Sep 10, 2026
traded Sep 9, 2026
+1dSEC Form 4

Evidence

0
KA
King Ryan ADirector, Co-Founder
CHYMChime Financial, Inc.
Derivative conversion · 10b5-1 plan
C—
34.9K sh
Sep 9, 2026Sep 10, 2026
traded Sep 9, 2026
+1dSEC Form 4

Evidence

0
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Derivative conversion · 10b5-1 plan
C—
12.8K sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

0
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Option exercise · 10b5-1 plan
M—
107.7K sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

0
KC
Kleinerman ChristianEVP, Product Management
SNOWSnowflake Inc.
Tax withholding · 10b5-1 plan
F$626K
1,858 sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

0
ES
Evans Katie SeitzSee Remarks
MGNIMAGNITE, INC.
Option exercise · 10b5-1 plan
M—
13.5K sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

0
DB
Dageville BenoitDirector
SNOWSnowflake Inc.
Tax withholding · 10b5-1 plan
F$187K
555 sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

0
MJ
McVeety Kristen JGC and Secretary
CRWVCoreWeave, Inc.
Option exercise · 10b5-1 plan
M—
97.5K sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC Form 4

Evidence

58
SD
Saavedra Jennifer D.Chief Human Resources Officer
DELLDell Technologies Inc.
Open-market sale
SELL$13.13M
25.3K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

51
TA
Tiran AssafEVP Cross Suez & Atlantic BU
ZIMZIM Integrated Shipping Services Ltd.
Open-market sale
SELL$70K
2,312 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

51
TJ
Tunnell JaneChief Marketing Officer
DELLDell Technologies Inc.
Open-market sale
SELL$2.85M
5,436 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

50
GJ
Grube JamesDirector
GMEGameStop Corp.
Open-market purchase
BUY$196K
10.3K sh
Sep 9, 2026Sep 9, 2026
traded Sep 9, 2026
+0dSEC Form 4

Evidence

48
EA
Elimelech ArikEVP HR & Organization
ZIMZIM Integrated Shipping Services Ltd.
Open-market sale
SELL$14K
458 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

43
CS
Cashman SteveChief Business Officer
BFLYButterfly Network, Inc.
Open-market sale
SELL$1.02M
140.1K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

43
ML
Muller Frank L.Director
BCALCalifornia BanCorp \ CA
Open-market purchase
BUY$9,959
450 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

41
LS
Landesberg StuartDirector
GROVGrove Collaborative Holdings, Inc.
Open-market purchase
BUY$248
241 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

40
PS
Peyovich Daniel SPresident & CEO
DYDYCOM INDUSTRIES INC
Open-market purchase
BUY$252K
850 sh
Sep 9, 2026Sep 9, 2026
traded Sep 9, 2026
+0dSEC Form 4

Evidence

39
AB
Aquilino BrianChief Operating Officer
GOLDGold.com, Inc.
Open-market sale
SELL$313K
6,667 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

38
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Open-market sale
SELL$231K
5,500 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

38
MM
Mulshine Brendan MartinCo-President and CRO
RYANRYAN SPECIALTY HOLDINGS, INC.
Open-market sale
SELL$1.62M
40.0K sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

37
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Open-market sale · 10b5-1 plan
SELL$28.69M
1.89M sh
Sep 9, 2026Sep 9, 2026
traded Sep 9, 2026
+0dSEC Form 4

Evidence

36
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Open-market sale · 10b5-1 plan
SELL$1.39M
8,843 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

36
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Open-market sale · 10b5-1 plan
SELL$1.39M
8,843 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

36
CM
Carlson MeganCAO and SVP, Finance
BFLYButterfly Network, Inc.
Open-market sale
SELL$101K
13.8K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

35
DS
Dotan SaarEVP Countries & BD
ZIMZIM Integrated Shipping Services Ltd.
Open-market sale
SELL$88K
2,890 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

35
LY
Lin Elizabeth YeuChief Medical Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$485K
5,386 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

35
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Open-market sale
SELL$989K
23.0K sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

34
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Open-market sale · 10b5-1 plan
SELL$6.98M
464.2K sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

34
SF
Sluis FrankCFO
ONONOn Holding AG
Open-market sale
SELL$19K
687 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

32
CA
Clerc AlexandreSVP, Customers
ULCCFrontier Group Holdings, Inc.
Open-market sale
SELL$20K
3,480 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

32
DS
Dotan SaarEVP Countries & BD
ZIMZIM Integrated Shipping Services Ltd.
Open-market sale
SELL$24K
800 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

32
LZ
Lindgardt ZhenyaDirector, Chief Executive Officer
SERASERA PROGNOSTICS, INC.
Open-market sale
SELL$40K
20.1K sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

32
LY
Lin Elizabeth YeuChief Medical Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$143K
1,590 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

32
CS
Chin Peter ScottChief Medical Officer
DNLIDenali Therapeutics Inc.
Open-market sale
SELL$37K
1,654 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

31
LY
Lin Elizabeth YeuChief Medical Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$458K
5,387 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence